Healthy Skepticism Library item: 7820

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

White K, Beall T.
Changing OTC landscape
Pharmaceutical Executive 2001 Mar; 21:82, 84, 86, 88, 90

Abstract:

Communications challenges facing the pharmaceutical industry, U.S. Food and Drug Administration (FDA), pharmacy and consumer organizations, and other involved parties as they deal with issues involving Rx-to-OTC switches are discussed, including drug labeling and reimbursement, the initiation of Rx-to-OTC switches by the pharmaceutical industry vs the FDA, and potential dual regulatory status for OTC products, i.e., a simultaneous Rx and OTC existence and/or the creation of a transitional class of OTC pharmaceuticals that would require pharmacist consultations.